eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Staff; Availability: Decisions for Investigational Device Exemption Clinical Investigations

Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Staff; Availability: Decisions for Investigational Device Exemption Clinical Investigations

Document ID: FDA-2011-D-0790-0004
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2011-33141
View Document:  View as format pdf View as format html

Details Information

Document Subtype: Notice of Extension
Received Date: December 27 2011, at 12:00 AM Eastern Standard Time
Start-End Page: 80948 - 80948
Page Count: 1
Comment Start Date: December 27 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: March 9 2012, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 13
David Forster - Comment
Posted: 02/28/2012     ID: FDA-2011-D-0790-0005

Mar 09,2012 11:59 PM ET
Consortium of Independent Review Boards (CIRB) - Comment
Posted: 02/28/2012     ID: FDA-2011-D-0790-0006

Mar 09,2012 11:59 PM ET
Cook Group, Inc. - Comment
Posted: 03/14/2012     ID: FDA-2011-D-0790-0007

Mar 09,2012 11:59 PM ET
The Procter & Gamble Company - Comment
Posted: 03/14/2012     ID: FDA-2011-D-0790-0016

Mar 09,2012 11:59 PM ET
Advanced Medical Technology Association (AdvaMed) - Comment
Posted: 03/14/2012     ID: FDA-2011-D-0790-0017

Mar 09,2012 11:59 PM ET

Related Documents

Total: 0
No documents available.